Hugel Inc - Asset Resilience Ratio

Latest as of March 2026: 29.57%

Hugel Inc (145020) has an Asset Resilience Ratio of 29.57% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩335.36 Billion

≈ $227.27 Million USD Cash + Short-term Investments

Total Assets

₩1.13 Trillion

≈ $768.68 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Hugel Inc's Asset Resilience Ratio has changed over time. Check Hugel Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Hugel Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Hugel Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩335.36 Billion	29.57%
Total Liquid Assets	₩335.36 Billion	29.57%

Asset Resilience Insights

Very High Liquidity: Hugel Inc maintains exceptional liquid asset reserves at 29.57% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Hugel Inc Industry Peers by Asset Resilience Ratio

Compare Hugel Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Hugel Inc (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Hugel Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	30.56%	₩329.07 Billion ≈ $223.01 Million	₩1.08 Trillion ≈ $729.76 Million	-14.48pp
2024-12-31	45.04%	₩423.12 Billion ≈ $286.74 Million	₩939.44 Billion ≈ $636.64 Million	-6.82pp
2023-12-31	51.86%	₩481.93 Billion ≈ $326.60 Million	₩929.25 Billion ≈ $629.74 Million	+1.95pp
2022-12-31	49.91%	₩523.99 Billion ≈ $355.10 Million	₩1.05 Trillion ≈ $711.42 Million	-4.77pp
2021-12-31	54.68%	₩552.13 Billion ≈ $374.17 Million	₩1.01 Trillion ≈ $684.28 Million	-7.98pp
2020-12-31	62.66%	₩599.20 Billion ≈ $406.07 Million	₩956.34 Billion ≈ $648.10 Million	-0.92pp
2019-12-31	63.58%	₩568.80 Billion ≈ $385.47 Million	₩894.69 Billion ≈ $606.32 Million	-1.93pp
2018-12-31	65.51%	₩601.56 Billion ≈ $407.67 Million	₩918.27 Billion ≈ $622.30 Million	-7.05pp
2017-12-31	72.56%	₩595.69 Billion ≈ $403.69 Million	₩820.93 Billion ≈ $556.33 Million	+37.19pp
2016-12-31	35.38%	₩104.11 Billion ≈ $70.55 Million	₩294.30 Billion ≈ $199.44 Million	+32.29pp
2015-12-31	3.08%	₩7.20 Billion ≈ $4.88 Million	₩233.57 Billion ≈ $158.29 Million	-9.54pp
2014-12-31	12.63%	₩12.28 Billion ≈ $8.32 Million	₩97.25 Billion ≈ $65.90 Million	--

pp = percentage points

About Hugel Inc

KQ:145020 Korea Biotechnology

Market Cap

$1.70 Billion

₩2.51 Trillion KRW

Market Cap Rank

#6636 Global

#151 in Korea

Share Price

₩232500.00

Change (1 day)

+3.56%

52-Week Range

₩214000.00 - ₩360000.00

All Time High

₩388000.00